Janux Therapeutics (JANX) Operating Margin (2021 - 2026)
Janux Therapeutics' (JANX) quarterly Operating Margin came in at 916.5% in Q1 2026, down 159.99% on a QoQ basis from 352.51% in Q3 2025.
Janux Therapeutics (JANX) Operating Margin (2021 - 2026) Analysis & Trends
Janux Therapeutics (JANX) has 6 years of Operating Margin data on file, last reported at 916.5% in Q1 2026.
- On a quarterly basis, Operating Margin changed N/A year-over-year to 916.5% in Q1 2026; TTM through Mar 2026 was 1143.11%, a 7351.0% increase from a year earlier, with the FY2025 full-year figure at 1576.67%, down 64309.0% from the prior year.
- Operating Margin for Q1 2026 stood at 916.5%, down from 352.51% in the prior quarter.
- Over the last five years, Operating Margin for JANX reached as high as 155.36% in Q2 2024 and fell as low as 8164.46% in Q3 2024.
- Historically, Operating Margin has averaged 1434.96% across 5 years, with a median of 852.23% in 2022.
- Across the five-year window, Operating Margin sank 753622 bps in 2024 and jumped 781195 bps in 2025, its largest moves.
- Year by year, Operating Margin stood at 642.04% in 2022, then declined by 2 bps to 655.71% in 2023, then slumped by 1145 bps to 8164.46% in 2024, then surged by 96 bps to 352.51% in 2025, then slumped by 160 bps to 916.5% in 2026.
- Per Business Quant data, the three most recent Operating Margin figures were 916.5% in Q1 2026, 352.51% in Q3 2025, and 8164.46% in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 16.51% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 31.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Janux Therapeutics | 985.11 Mn | 985.11 Mn | - | -916.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -916.50% |
| Sep 30, 2025 | -352.51% |
| Sep 30, 2024 | -8,164.46% |
| Jun 30, 2024 | -155.36% |
| Mar 31, 2024 | -1,610.30% |
| Dec 31, 2023 | -655.71% |
| Sep 30, 2023 | -628.25% |
| Jun 30, 2023 | -1,962.91% |
| Mar 31, 2023 | -990.28% |
| Dec 31, 2022 | -642.04% |
| Sep 30, 2022 | -994.04% |
| Jun 30, 2022 | -729.85% |
| Mar 31, 2022 | -852.23% |
| Dec 31, 2021 | -834.78% |
| Sep 30, 2021 | -940.72% |
| Jun 30, 2021 | -1,297.10% |
| Mar 31, 2021 | -601.05% |